An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Moderna is down 80% from its 52-week ... An opportunity for an early demonstration of efficacy in the phase 3 trial of MRNA's CMV vaccine has passed, but a final analysis can still arrive in ...

We recently compiled a list of the 10 Firms Fall Amid Disappointing Earnings Performance. In this article, we are going to ...

vaccine, which did not meet the criteria for early efficacy in a Phase 3 trial. The study is continuing and Moderna anticipates final efficacy data later this year. See Also: Teva Pharmaceutical ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

Vaccine efficacy in children six months up to age ... There were no hospitalizations or deaths. Moderna said this was consistent with what had been observed among adults, and the company was ...

The bill would implement a moratorium for a decade. “I am not against vaccination in any way,” the freshman lawmaker said.

Although their vaccine candidates remained ... long-standing collaboration between Merck and Moderna, as well as the incredibly favorable initial efficacy data for mRNA+KEYTRUDA combination ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...